Literature DB >> 17854240

Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders.

Sumita G Manwani1, Kathleen A Szilagyi, Benjamin Zablotsky, John Hennen, Margaret L Griffin, Roger D Weiss.   

Abstract

OBJECTIVE: To examine patterns of adherence to mood stabilizers and reasons for nonadherence in patients with bipolar disorder, with and without substance use disorder (SUD).
METHOD: From December 2003 to October 2004, 115 patients with DSM-IV-diagnosed bipolar disorder (58 with SUD and 57 without SUD) were administered a structured interview regarding their lifetime experience with mood stabilizers.
RESULTS: Lifetime adherence with mood stabilizers for the SUD group was 65.5%, versus 82.5% for the non-SUD group (p < .05). Lifetime lithium adherence for the SUD group was lower than for the non-SUD group (65.9% vs. 85.0%, p < .05). Substance-related reasons were more commonly cited by the SUD group than the non-SUD group. In contrast, pill- and dosage-related reasons were more frequently endorsed by the non-SUD group than the SUD group.
CONCLUSION: In bipolar disorder patients, those with co-occurring SUD were less adherent than those without SUD. The SUD group was also less adherent to lithium than the non-SUD group. The reasons for nonadherence differed by presence or absence of a SUD. Physicians should be alert to these differences in their clinical practices while prescribing medications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17854240     DOI: 10.4088/jcp.v68n0802

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  15 in total

1.  Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate.

Authors:  James J Prisciandaro; Stacia M DeSantis; Cody Chiuzan; Delisa G Brown; Kathleen T Brady; Bryan K Tolliver
Journal:  Alcohol Clin Exp Res       Date:  2011-09-20       Impact factor: 3.455

2.  Predictors of non-stabilization during the combination therapy of lithium and divalproex in rapid cycling bipolar disorder: a post-hoc analysis of two studies.

Authors:  Keming Gao; David E Kemp; Zuowei Wang; Stephen J Ganocy; Carla Conroy; Marry Beth Serrano; Martha Sajatovic; Robert L Findling; Joseph R Calabrese
Journal:  Psychopharmacol Bull       Date:  2010

Review 3.  Medication nonadherence in bipolar disorder: a narrative review.

Authors:  Ibrahim Jawad; Stuart Watson; Peter M Haddad; Peter S Talbot; R Hamish McAllister-Williams
Journal:  Ther Adv Psychopharmacol       Date:  2018-10-16

4.  Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder.

Authors:  Christian J Teter; Anthony E Falone; Amanda M Bakaian; Chunhao Tu; Dost Ongür; Roger D Weiss
Journal:  Psychiatry Res       Date:  2011-06-22       Impact factor: 3.222

5.  Predictors of clinical trial dropout in individuals with co-occurring bipolar disorder and alcohol dependence.

Authors:  James J Prisciandaro; Julie Rembold; Delisa G Brown; Kathleen T Brady; Bryan K Tolliver
Journal:  Drug Alcohol Depend       Date:  2011-05-06       Impact factor: 4.492

6.  Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study.

Authors:  Zuowei Wang; Keming Gao; David E Kemp; Philip K Chan; Mary Beth Serrano; Carla Conroy; Yiru Fang; Stephen J Ganocy; Robert L Findling; Joseph R Calabrese
Journal:  Psychopharmacol Bull       Date:  2010

7.  Increased risk for suicidal behavior in comorbid bipolar disorder and alcohol use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

Authors:  Maria A Oquendo; Dianne Currier; Shang-Min Liu; Deborah S Hasin; Bridget F Grant; Carlos Blanco
Journal:  J Clin Psychiatry       Date:  2010-07       Impact factor: 4.384

8.  Bipolar-I patient characteristics associated with differences in antimanic medication prescribing.

Authors:  Alisa B Busch; Richard G Frank; Gary Sachs; Sharon-Lise T Normand
Journal:  Psychopharmacol Bull       Date:  2009

9.  Recovery of cognitive functioning in patients with co-occurring bipolar disorder and alcohol dependence during early remission from an acute mood episode.

Authors:  Boaz Levy; Emily Manove; Roger D Weiss
Journal:  Ann Clin Psychiatry       Date:  2012-05       Impact factor: 1.567

10.  Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study.

Authors:  Trine V Lagerberg; Ole A Andreassen; Petter A Ringen; Akiah O Berg; Sara Larsson; Ingrid Agartz; Kjetil Sundet; Ingrid Melle
Journal:  BMC Psychiatry       Date:  2010-01-27       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.